Trading

Data

Solutions

Insights

HeartFlow Stock

heartflow.comHealthcareFounded: 2007Funding to Date: $528.88MM

HeartFlow is revolutionizing precision heart care, combining human ingenuity with advanced AI technology. They began their journey to improve coronary artery disease diagnosis with FFRCT and have now expanded their product portfolio to include anatomic stenosis and plaque information. This company was founded by Charles Taylor, Christopher Zarins, and John Stevens in 2007 and is headquartered in Redwood City, CA.

Buy or sell HeartFlow stock Learn more about HeartFlow IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

View Enterprise Value for HeartFlow.

Register Today

HeartFlow investors also invested in these private companies

Baillie Gifford

Redwood Materials, PsiQ, Nuro, Indigo, Discord, Gopuff, Carbon, Ola, Grammarly, Thumbtack

Wellington Management

Dataminr, Patreon, Lookout, Synthego, SeatGeek, Airbnb, Greenlight, HeartFlow, Boundless Bio, WeWork

US Venture Partners

Postman, Observe.AI, H2O.ai, Aryaka, HeartFlow, Apollo, Shoulder Innovations, MinIO, PubMatic, ShopClues

Capricorn Investment Group

Helion Energy, Redwood Materials, HeartFlow, Innovium, Aspiration, Joby Aviation, Porch

Bain Capital

Rubrik, FourKites, Roofstock, Sysdig, Moveworks, Signifyd, Optimizely, HeartFlow, ShipBob, Airbase

Sweetwater Private Equity

ThoughtSpot, Savage X Fenty, HeartFlow, Automattic, Blink Health

Spur Capital Partners

Rubrik, Netskope, Outreach, Flock Safety, Guild Education, Calm, Cybereason, HeartFlow, Anduril, Oyo

Venture Science

Domino Data Lab, HeartFlow

Sandbox Industries

HeartFlow, Geltor

Janus Capital Group

HeartFlow

HealthCor Partners Management

HeartFlow

Team

Management Team

Campbell Rogers MD

Chief Medical Officer & Executive Vice President

Charles Taylor Ph.D

Co-Founder, Chief Scientific Officer & Board Member

Noemi Espinosa JD

Chief Ethics & Compliance Officer & General Counsel

Christopher Zarins MD

Co-Founder, Senior Advisor on Clinical Science & Senior Vice President of Medical Affairs

John Farquhar

Chief Executive Officer, President & Board Member

Monica Tellado

Chief Financial Officer

Board Members

Jeffrey Lightcap

HealthCor Partners Management

Casey Tansey

US Venture Partners

Barry Uphoff

Capricorn Investment Group

Other companies like HeartFlow in the Healthcare sector

Altos Labs

Sector

Healthcare

Last Round Est. Valuation

$3.67B

Acelyrin

Sector

Healthcare

Last Round Est. Valuation

$809.52MM

Colossal Biosciences

Sector

Healthcare

Last Round Est. Valuation

$1.01B

Sector

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Last Round Est. Valuation

$396.01MM

Synchron

Sector

Healthcare

Last Round Est. Valuation

$400.53MM

Alzheon

Sector

Healthcare

Last Round Est. Valuation

$1.53B

News

Forbes 02/04/2019

Top Five Digital Health Technologies in 2019

For 2019, we asked companies around the world one basic question: “Please indicate the key technology which you believe will have the most profound impact on the healthcare industry during 2019?” The results are not very surprising:

Forbes 08/29/2018

Why HeartFlow’s Data From This Weekend Don’t Change Anything

The $1.5 billion health-tech startup HeartFlow has a noninvasive test for heart disease based on machine learning analysis of CT scans. Two new studies are unlikely to win over its critics.

Forbes 08/27/2018

HeartFlow Has Raised $500 Million For A Test To Detect Heart Disease. Does It Make Patients Better Off?

The valuation is based on a big idea: a noninvasive test that peers into a patient’s coronary arteries to see how blocked they are.

Frequently Asked Questions

Updated on: Jun 1, 2023

Popular Topics

Popular Topics

HeartFlow Stock

Register for Details